Should I buy Sempra (SRE) stock or is it too late?
⭐ The most reliable of them, either direction: Barclays — 73% of its targets hit on this sector (317 calls tested). It aims for $90 (+9.3 %), call made on October 13, 2026, maturing on October 13, 2027 (1 d ago).
Firm-by-firm track record on Sempra
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Morgan Stanley | 70 % | +17.8 % | 10 | $100 +21% |
| Wells Fargo | 72 % | +10.7 % | 25 | $115 +40% |
| Barclays | 80 % | +8.4 % | 15 | $90 +9% |
| Mizuho | 70 % | +8.1 % | 10 | $84 +2% |
| BMO Capital | 71 % | +8.0 % | 7 | $102 +24% |
| UBS | 75 % | +7.5 % | 12 | $100 +21% |
| B of A Securities | 67 % | +9.9 % | 6 | — |
| Keybanc | 86 % | +7.1 % | 7 | — |
✅ Reasons to believe
- 78% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Median price target $97, i.e. +17% from the current price ($82).
- The most reliable firm on SRE, Citigroup (100% hit rate, 3 scored calls), targets $99 (call made on November 24, 2025, maturing on November 24, 2026) (+20%) in its most recent call.
- 5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Pays a dividend (2.9% yield), raised for 15 years — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 9 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on SRE
Median target $97 (+17%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Sempra now?
We won't decide for you. The facts: 78% of analysts rate it a buy, median target $97 (+17%), and Citigroup (most reliable on SRE, 100%) targets $99. Weigh that against valuation (P/E ~24). This is not personalized advice.
Is it too late to invest in Sempra?
Not according to analysts: the median target ($97) is still +17% above the current price ($82) (most reliable on SRE: Citigroup, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Sempra still worth investing in?
It depends on the gap between the price ($82) and its estimated value: analysts target $97 on median (+17%), with 78% buys (most reliable on SRE: Citigroup, 100%). Cross-check with their real reliability on SRE and the cautions above. Information, not advice.
What's the main risk in buying SRE?
The consensus is not unanimous: of 9 ratings, 2 are neutral.
→ Go deeper: the full Sempra profile (consensus, analyst reliability, price target, performance).